Show Health and Fitness Publications

Mon, April 2, 2012

[ Mon, Apr 02nd 2012 ] - Market Wire

Synageva BioPharma and Mitsubishi Tanabe Pharma C .. and Development Collaboration with Second Program

[ Mon, Apr 02nd 2012 ] - Market Wire

BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

[ Mon, Apr 02nd 2012 ] - Market Wire

Hansen Medical Names Joseph Guido as Vice President Marketing &;; Business Development

[ Mon, Apr 02nd 2012 ] - Market Wire

AVID Bioservices Highlights Antibody Engineering, Expression and Bioassay Expertise at AACR

[ Mon, Apr 02nd 2012 ] - Market Wire

Hospira to Host Conference Call for First-quarter 2012 Results

[ Mon, Apr 02nd 2012 ] - Market Wire

Cytomedix to Present at the 11th Annual Needham Healthcare Conference

[ Mon, Apr 02nd 2012 ] - Market Wire

Solta Medical Introduces Liposonix at AMWC in Mon .. io of Aesthetic Energy Devices Reaches Industry M

[ Mon, Apr 02nd 2012 ] - Market Wire

First Cancer Center in Thailand Commences Treatin .. ystem for High Precision Image-Guided Radiotherap

[ Mon, Apr 02nd 2012 ] - Market Wire

Sangamo BioSciences Announces Publication in Natu .. of ZFN Technology to Engineer Safer and More Eff

[ Mon, Apr 02nd 2012 ] - Market Wire

Co-Founder of Biotech Powerhouse, ImClone Systems .. the Same Type of Potential at Neptune Subsidiary

[ Mon, Apr 02nd 2012 ] - Market Wire

Oncolytics Biotech Inc. Completes Enrollment in F .. Stage of Phase III Study in Head and Neck Cancers

[ Mon, Apr 02nd 2012 ] - Market Wire

Keryx Biopharmaceuticals Announces Top-Line Data .. rifosine (KRX-0401) X-PECT Phase 3 Clinical Trial

[ Mon, Apr 02nd 2012 ] - Market Wire

Life Technologies Announces Expansion of TaqMan Mutation Detection Assays

[ Mon, Apr 02nd 2012 ] - Market Wire

Implant Sciences Hires Marketing Programs Manager

[ Mon, Apr 02nd 2012 ] - Market Wire

AVI BioPharma Announces Eteplirsen Meets Primary .. nificant Increase in Dystrophin at 24 Weeks Compa

[ Mon, Apr 02nd 2012 ] - Market Wire

Ingenuity Systems et Life Technologies prsentent .. analyse de l'expression gntique par la PCR en tem

[ Mon, Apr 02nd 2012 ] - Market Wire

Ingenuity Systems y Life Technologies lanzan una .. a extremo para el anlisis de expresin gentica PCR

[ Mon, Apr 02nd 2012 ] - Market Wire

Ingenuity Systems and Life Technologies Introduce .. lution for Real-Time PCR Gene Expression Analysis

[ Mon, Apr 02nd 2012 ] - Market Wire

Inovio Pharmaceuticals Receives Defense Departmen .. or Bioterrorism-Related Synthetic Vaccine Program

Sun, April 1, 2012

[ Sun, Apr 01st 2012 ] - Market Wire

Shionogi-ViiV Healthcare Announces Initial Data f .. om Pivotal Phase III Study of Dolutegravir in HIV

[ Sun, Apr 01st 2012 ] - Market Wire

Accuray lis potilaiden hoitovaihtoehtoja Suomessa

[ Sun, Apr 01st 2012 ] - Market Wire

Life Technologies Showcases Leading Technologies .. r Cancer Research at the AACR Annual Meeting 2012

Sat, March 31, 2012

[ Sat, Mar 31st 2012 ] - Market Wire

CytoSorbents Corporation Reports Full Year 2011 Financial Results and Corporate Update

[ Sat, Mar 31st 2012 ] - Market Wire

Cempra Inc.'s Solithromycin (CEM-101) Demonstrate .. ntibiotic-Resistant Neisseria Gonorrhoeae Isolate

[ Sat, Mar 31st 2012 ] - Market Wire

Cempra Inc. Presents Full Data Set of Phase 2 Cli .. hromycin) in Community-Acquired Bacterial Pneumon

Fri, March 30, 2012

[ Fri, Mar 30th 2012 ] - Market Wire

Medtronic Reaches Settlement of Shareholder Class Action

[ Fri, Mar 30th 2012 ] - Market Wire

Leatt Corp. Reports Results for 2011

[ Fri, Mar 30th 2012 ] - Market Wire

Telik Announces Reverse Split of Common Stock

[ Fri, Mar 30th 2012 ] - Market Wire

Cardium Announces U.S. Market Introduction of Excellagena"

[ Fri, Mar 30th 2012 ] - Market Wire

Data From AVI BioPharma's Infectious Disease Prog .. 2nd European Congress of Clinical Microbiology an

[ Fri, Mar 30th 2012 ] - Market Wire

ChemoCentryx Announces 2011 Fourth Quarter and Full Year Financial Results

[ Fri, Mar 30th 2012 ] - Market Wire

Steady Dividends From Pfizer and Kraft Looking Strong

[ Fri, Mar 30th 2012 ] - Market Wire

Cambridge Heart Reports Results for the Three and Twelve Months Ended December 31, 2011

[ Fri, Mar 30th 2012 ] - Market Wire

Cempra, Inc. Reports Full Year 2011 Financial Results

[ Fri, Mar 30th 2012 ] - Market Wire

Isis Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference

[ Fri, Mar 30th 2012 ] - Market Wire

Medivation Announces Poster Presentations at AACR Annual Meeting 2012

[ Fri, Mar 30th 2012 ] - Market Wire

DaVita Teammates Donate Record Numbers of Shoes to Santa Ana School Children

[ Fri, Mar 30th 2012 ] - Market Wire

DaVitaas Mark Shapiro Featured at National Summit on Home Dialysis Policy

[ Fri, Mar 30th 2012 ] - Market Wire

Synthetic Biologics Reports 2011 Year End Financial Results

[ Fri, Mar 30th 2012 ] - Market Wire

00 am ET March 30, 2012 to Discuss Todayas Favora .. t Trastuzumab Emtansine (T-DM1) and about IMGN901

[ Fri, Mar 30th 2012 ] - Market Wire

ImmunoGen, Inc. Announces Initiation of Phase II Evaluation of Its IMGN901 Product Candidate

[ Fri, Mar 30th 2012 ] - Market Wire

Abbott's PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking

[ Fri, Mar 30th 2012 ] - Market Wire

Crown Dynamics Corp Announces New Chief Financial Officer

Thu, March 29, 2012

[ Thu, Mar 29th 2012 ] - Market Wire

Accuray Signs Master Research and Collaboration Agreement With University of Heidelberg

[ Thu, Mar 29th 2012 ] - Market Wire

ThermoGenesis Announces AABB Accreditation for Cord Blood Products Customer in China

[ Thu, Mar 29th 2012 ] - Market Wire

ZYTO Corp Chairman and CEO to Provide Business Update

[ Thu, Mar 29th 2012 ] - Market Wire

One Year Data Provide Evidence of Effectiveness a .. y of REPLAGAL (agalsidase alfa) in Fabry Patients

[ Thu, Mar 29th 2012 ] - Market Wire

Critical Outcome Technologies Inc. Reports Fiscal 2012 Third Quarter Financial Results

[ Thu, Mar 29th 2012 ] - Market Wire

Cardica Applies CE Mark to Its MicroCutter XCHANGEa" 30 Surgical Cutting and Stapling Device

[ Thu, Mar 29th 2012 ] - Market Wire

Discovery Labs Reports Fourth Quarter Financial Results and Highlights Recent Milestones

[ Thu, Mar 29th 2012 ] - Market Wire

Derma Sciences to Acquire MedEfficiency;; .. Wound Care Product Offering with High-Growth, Mar

[ Thu, Mar 29th 2012 ] - Market Wire

Omeros Reports Allowance of Additional Patent for Ophthalmology Product OMS302

[ Thu, Mar 29th 2012 ] - Market Wire

Cempra, Inc. to Present at the Needham 11th Annual Health Care Conference

[ Thu, Mar 29th 2012 ] - Market Wire

VentriPoint 3D Heart Analysis System First to Be Approved for Pulmonary Hypertension in Europe

[ Thu, Mar 29th 2012 ] - Market Wire

DaVita Gives a Year of Free Health Insurance for Healthy Lifestyles

[ Thu, Mar 29th 2012 ] - Market Wire

MEDNAX Announces Acquisition of Three Practices in Sacramento, Calif.

[ Thu, Mar 29th 2012 ] - Market Wire

Sinovac Announces Director Appointment

[ Thu, Mar 29th 2012 ] - Market Wire

Five Oral Presentations on Clinical Experience Wi .. at Society of Interventional Radiology Conference

[ Thu, Mar 29th 2012 ] - Market Wire

Sinovac's EV71 Vaccine Phase I Clinical Data for .. ic Hand, Foot, Mouth Disease Published in Vaccine

[ Thu, Mar 29th 2012 ] - Market Wire

Astex Pharmaceuticals to Present at AACR Annual Meeting

[ Thu, Mar 29th 2012 ] - Market Wire

AirWare Labs Announces the Release of "BREATHE," First of the New Product Line, "AIR"

Wed, March 28, 2012

[ Wed, Mar 28th 2012 ] - Market Wire

MethylGene to Present at the American Association for Cancer Research (AACR) Annual Meeting

[ Wed, Mar 28th 2012 ] - Market Wire

Oncothyreon Announces Proposed Public Offering of Common Stock

[ Wed, Mar 28th 2012 ] - Market Wire

Warnex to Delay Release of its Financial Statements

[ Wed, Mar 28th 2012 ] - Market Wire

Law Offices of Howard G. Smith Announces Continued Investigation of ISTA Pharmaceuticals, Inc.

[ Wed, Mar 28th 2012 ] - Market Wire

LifeSci Advisors Announces Investment Opinion on DiagnoCure, Inc.

[ Wed, Mar 28th 2012 ] - Market Wire

Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer

[ Wed, Mar 28th 2012 ] - Market Wire

Neuralstem ALS Stem Cell Trial Interim Results Reported in the Journal, STEM CELLS

[ Wed, Mar 28th 2012 ] - Market Wire

Cynosure to Present at 11th Annual Needham Healthcare Conference

[ Wed, Mar 28th 2012 ] - Market Wire

Analytical Reports on Hologic Inc. and Medtronic .. ve Long-Term Outlook for Medical Equipment Makers

[ Wed, Mar 28th 2012 ] - Market Wire

Advanced Cell Technology and PharmAthene Poised to Benefit From Positive Legislation

[ Wed, Mar 28th 2012 ] - Market Wire

Optimer Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference

[ Wed, Mar 28th 2012 ] - Market Wire

AMRI CFO to Present at 11th Annual Needham Healthcare Conference

[ Wed, Mar 28th 2012 ] - Market Wire

IBEX Reports Results for the Six Months Ended January 31, 2012

[ Wed, Mar 28th 2012 ] - Market Wire

Mylan Launches Generic Version of Seroquel Tablets, 25 mg

[ Wed, Mar 28th 2012 ] - Market Wire

Exclusive Video Q&;;A With President and CEO of BioDelivery Sciences

[ Wed, Mar 28th 2012 ] - Market Wire

Implant Sciences Continues Global Shipments of It .. -H150 Portable Explosives Trace Detection Devices

[ Wed, Mar 28th 2012 ] - Market Wire

Clovis Oncology Announces Enrollment of First Pat .. y of Oral EGFR Mutant-Selective Inhibitor CO-1686

[ Wed, Mar 28th 2012 ] - Market Wire

Santarus to Present at 11th Annual Needham Healthcare Conference

Tue, March 27, 2012

[ Tue, Mar 27th 2012 ] - Market Wire

Glancy Binkow & Goldberg LLP Announces Continued Investigation of ISTA Pharmaceuticals, Inc.

[ Tue, Mar 27th 2012 ] - Market Wire

Lexicon Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference

[ Tue, Mar 27th 2012 ] - Market Wire

Cumberland Pharmaceuticals to Present at Needham .. Sciences Conference in New York on April 3, 2012

[ Tue, Mar 27th 2012 ] - Market Wire

Neurocrine Biosciences to Present at the 11th Annual Needham Healthcare Conference

[ Tue, Mar 27th 2012 ] - Market Wire

TheraBiogen Offers Thera Max Cold and Flu to Indi .. of Health to Aid in Outbreak of Swine Flu (H1N1)

[ Tue, Mar 27th 2012 ] - Market Wire

NASDAQ Panel Grants Skystar's Request for Continued Listing on NASDAQ Stock Market

[ Tue, Mar 27th 2012 ] - Market Wire

Lorus Therapeutics Announces Positive Results from Its Small Molecule Antimicrobial Program

[ Tue, Mar 27th 2012 ] - Market Wire

ISTA Pharmaceuticals Announces Issuance of U.S. Patent for PROLENSA(TM)

[ Tue, Mar 27th 2012 ] - Market Wire

Dyax Corp. to Participate in the Needham & Company 11th Annual Healthcare Conference

[ Tue, Mar 27th 2012 ] - Market Wire

Omeros Names Dr. Patrick Gray as Scientific Fellow

[ Tue, Mar 27th 2012 ] - Market Wire

DaVitaas Chief Medical Officer Blogs for KevinMD.com

[ Tue, Mar 27th 2012 ] - Market Wire

Life Technologies Launches Ion AmpliSeqa" Custom .. of Disease-Related Research Samples for Analysis

[ Tue, Mar 27th 2012 ] - Market Wire

Data on AVEO Pharmaceuticalsa Tivozanib and AV-203 to Be Presented at AACR Annual Meeting 2012

[ Tue, Mar 27th 2012 ] - Market Wire

Pacira Pharmaceuticals, Inc. Reports 2011 Financial Results

[ Tue, Mar 27th 2012 ] - Market Wire

Delcath Announces Agreement With Istituto Naziona .. ascale for Further Expansion of CHEMOSAT in Italy

[ Tue, Mar 27th 2012 ] - Market Wire

Aetna Names David Healy General Manager of Europe Region

[ Tue, Mar 27th 2012 ] - Market Wire

Inovio Appoints Retired Merck Vaccines President Dr. Adel Mahmoud to its Board of Directors

[ Tue, Mar 27th 2012 ] - Market Wire

Waters, Ireland's NIBRT Partner on Training and Research to Advance Burgeoning Biopharma Industry

Mon, March 26, 2012

[ Mon, Mar 26th 2012 ] - Market Wire

Cynapsus Therapeutics Reports 2011 Financial Results and Highlights Key Developments

[ Mon, Mar 26th 2012 ] - Market Wire

Medtronic-Sponsored Study Finds Pacemakers Reduce Fainting in Patients

[ Mon, Mar 26th 2012 ] - Market Wire

INSYS Therapeutics Announces the Availability of .. yl sublingual spray) for Breakthrough Cancer Pain

[ Mon, Mar 26th 2012 ] - Market Wire

Response Genetics, Inc. Announces Appointment of .. h.D., as Vice President, Research and Development

[ Mon, Mar 26th 2012 ] - Market Wire

Sunshine Biopharma and Binghamton University to P .. ng American Association for Cancer Research Meeti

[ Mon, Mar 26th 2012 ] - Market Wire

Accuray Rolls Out PlanTouch for the CyberKnife System

[ Mon, Mar 26th 2012 ] - Market Wire

GenVec Awarded Grant for Antigen Discovery Project

[ Mon, Mar 26th 2012 ] - Market Wire

A.P. Pharma Announces Fourth Quarter and Full Yea .. 1 Financial Results and Provides Update on APF530

[ Mon, Mar 26th 2012 ] - Market Wire

Impax Laboratories Enters Into Development, Supply and Distribution Agreement with TOLMAR, Inc.

[ Mon, Mar 26th 2012 ] - Market Wire

ARIAD Announces Presentations of Preclinical Data .. an Association for Cancer Research Annual Meeting

[ Mon, Mar 26th 2012 ] - Market Wire

Aeterna Zentaris to Present Preclinical Data for .. Perifosine and AEZS-136 at Upcoming AACR Meeting

[ Mon, Mar 26th 2012 ] - Market Wire

Pozen's CEO Responds to Questions About His Firm' .. elopments and Positive Key Clinical Trial Results

[ Mon, Mar 26th 2012 ] - Market Wire

Oculus CEO Says Company Continues to Generate New .. aunching More FDA Cleared Products Despite Doubte

[ Mon, Mar 26th 2012 ] - Market Wire

Warnex Comments on Its Operations

[ Mon, Mar 26th 2012 ] - Market Wire

Delcath Expands Global Marketing Team With Key Pharma Oncology Hire

[ Mon, Mar 26th 2012 ] - Market Wire

AngioDynamics Establishes Strategic Relationship with Microsulis Medical Ltd.

[ Mon, Mar 26th 2012 ] - Market Wire

BioLife Solutions Announces Record 4th Quarter an .. 2011 Financial Results and Provides 2012 Outlook

[ Mon, Mar 26th 2012 ] - Market Wire

Inovio Receives U.S. Patent for SynCon H1N1 Influenza Universal Vaccine

Sun, March 25, 2012

[ Sun, Mar 25th 2012 ] - Market Wire

Illumina Comments on Second Extension of Rocheas Unsolicited Tender Offer

[ Sun, Mar 25th 2012 ] - Market Wire

US Court Denies Preliminary Injunction Applicatio .. Dismisses AstraZenecaas Lawsuit without Prejudice

[ Sun, Mar 25th 2012 ] - Market Wire

Pharming and Hyupjin Corporation announce commercialisation agreement for RUCONEST in Korea

[ Sun, Mar 25th 2012 ] - Market Wire

Landmark Analysis of Year Two Data From PLATINUM .. Superior Efficacy of PROMUS Elementa" Platinum Ch

[ Sun, Mar 25th 2012 ] - Market Wire

Analysis of Two Randomized Clinical Trials Identi .. Stent Deformation With Boston Scientific Platinum

[ Sun, Mar 25th 2012 ] - Market Wire

Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study

[ Sun, Mar 25th 2012 ] - Market Wire

Nordion lanza las dosis personalizadas para TheraSphere en Europa y Canad

[ Sun, Mar 25th 2012 ] - Market Wire

Nordion Launches Custom Doses for TheraSphere Liver Cancer Therapy in Europe and Canada

[ Sun, Mar 25th 2012 ] - Market Wire

Nordion fhrt patientenspezifische Dosierungen fr .. rebstherapie TheraSphere in Europa und Kanada ein

[ Sun, Mar 25th 2012 ] - Market Wire

Nordion lance les doses personnalises pour TheraS .. itement du cancer du foie, en Europe et au Canada

[ Sun, Mar 25th 2012 ] - Market Wire

USANA Health Sciences ouvre en France et en Belgique

Sat, March 24, 2012

[ Sat, Mar 24th 2012 ] - Market Wire

Medtronic Resolute Drug-Eluting Stent Delivers Du .. nical Outcomes Through Two Years in Major Studies

[ Sat, Mar 24th 2012 ] - Market Wire

Data Presented at ACC Reinforce Positive Clinical .. r Patients Receiving Medtronicas CoreValve System

Fri, March 23, 2012

[ Fri, Mar 23rd 2012 ] - Market Wire

Sirona Closes Non-Brokered Private Placement of $1,406,500

[ Fri, Mar 23rd 2012 ] - Market Wire

NeuroMetrix Reports Nasdaq Communication

[ Fri, Mar 23rd 2012 ] - Market Wire

Convocation Annual General Shareholder Meeting

[ Fri, Mar 23rd 2012 ] - Market Wire

Nordion stellt auf dem SIR Annual Scientific Meet .. sche Tools fr die Behandlung von Leberkrebs mit T

[ Fri, Mar 23rd 2012 ] - Market Wire

SBA Approves Mentor-Protg Agreement Between Human .. Military and Professional Management Enterprises

[ Fri, Mar 23rd 2012 ] - Market Wire

Milberg LLP Announces Class Action Lawsuit Agains .. One Medical, Inc.;; Launches Case Website

[ Fri, Mar 23rd 2012 ] - Market Wire

Daxor Announces That Shertech Pharmacy Acquires BVA-100 Blood Volume Analyzer

[ Fri, Mar 23rd 2012 ] - Market Wire

Positron Receives Nuclear Regulatory Commission Manufacturing and Distribution License

[ Fri, Mar 23rd 2012 ] - Market Wire

Repligen Announces FDA Advisory Committee Date for SecreFloa" NDA

[ Fri, Mar 23rd 2012 ] - Market Wire

Nordion lanza las herramientas mdicas mejoradas para el tratamiento de cncer de hgado TheraSphere

[ Fri, Mar 23rd 2012 ] - Market Wire

OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters

[ Fri, Mar 23rd 2012 ] - Market Wire

CareFusion Showcases Solutions to Improve Operati .. ciation of periOperative Registered Nurses Congre

[ Fri, Mar 23rd 2012 ] - Market Wire

HealthSouth Names Dean Taggart as Inspector General

[ Fri, Mar 23rd 2012 ] - Market Wire

Analytical Reports on Abbott Laboratories and Gla .. thKline plc - Drug Manufacturers Facing Headwinds

[ Fri, Mar 23rd 2012 ] - Market Wire

Promising Data Presented On GenVec RSV Program

[ Fri, Mar 23rd 2012 ] - Market Wire

BYETTA Approved for Use with Basal Insulin in Europe

[ Fri, Mar 23rd 2012 ] - Market Wire

Covidien neemt definitief Newport Medical Instruments over

[ Fri, Mar 23rd 2012 ] - Market Wire

CER Research Responds to Abbott Laboratories on China Infant Formula Report

Thu, March 22, 2012

[ Thu, Mar 22nd 2012 ] - Market Wire

Community Health Systems, Inc. Announces $300 Million Receivables Securitization Program

[ Thu, Mar 22nd 2012 ] - Market Wire

The Ensign Group Announces E-Prize! Competition

[ Thu, Mar 22nd 2012 ] - Market Wire

Prestige Brands espera informar un aumento aproxi .. y una ganancia ajustada por accin de aproximadame

[ Thu, Mar 22nd 2012 ] - Market Wire

Redesigned Quest Diagnostics Website Features New .. cate and Engage Healthcare Providers and Patients

[ Thu, Mar 22nd 2012 ] - Market Wire

AstraZeneca Announces Increased Coverage of BRILI .. Preferred Formulary Status on Medco Health Solut

[ Thu, Mar 22nd 2012 ] - Market Wire

Healthnostics Announces Major Expansion

[ Thu, Mar 22nd 2012 ] - Market Wire

Boston Scientific Begins U.S. and International L .. nch of WallFlex Biliary Transhepatic Stent System

[ Thu, Mar 22nd 2012 ] - Market Wire

Fallon Community Health Plan and Magellan Health .. e for Opportunity to Participate in Stateas Dual-

[ Thu, Mar 22nd 2012 ] - Market Wire

Endo Acquires Johnson Matthey's Oxymorphone Patent

[ Thu, Mar 22nd 2012 ] - Market Wire

Supreme Court Denies Apotex's Petition for a Writ of Certiorari

[ Thu, Mar 22nd 2012 ] - Market Wire

ImmunoCellular Therapeutics Licenses Novel Immuno .. peutic Target EphA2 from University of Pittsburgh

[ Thu, Mar 22nd 2012 ] - Market Wire

Trimel Announces Positive Tefina(TM) Pharmacokinetic Study Results

[ Thu, Mar 22nd 2012 ] - Market Wire

MELA Sciences Announces Agreement With Quintiles .. rcial Support Services for MelaFind(R) in Germany

[ Thu, Mar 22nd 2012 ] - Market Wire

BioLineRx Reports Fourth Quarter and Calendar 2011 Results

[ Thu, Mar 22nd 2012 ] - Market Wire

Isis Pharmaceuticals Hosts Dr. Raul Santos to Rev .. Have Been Presented at ISA 2012 - XVI Internation

[ Thu, Mar 22nd 2012 ] - Market Wire

Macrogen, Inc. Increases Investment in Illuminaas Next-Generation Sequencing Technology

[ Thu, Mar 22nd 2012 ] - Market Wire

OncoSec Selected to Present Data at Upcoming Head and Neck Cancer Conferences

[ Thu, Mar 22nd 2012 ] - Market Wire

PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting

Wed, March 21, 2012

[ Wed, Mar 21st 2012 ] - Market Wire

Regeneron Announces Data Publication and Presenta .. tial First-in-Class Lipid-Lowering PCSK9 Antibody

[ Wed, Mar 21st 2012 ] - Market Wire

Gentiva Health Services Updates Presentation Time .. al High Yield Bond and Syndicated Loan Conference

[ Wed, Mar 21st 2012 ] - Market Wire

3SBio Inc. Announces Changes to its Board of Directors

[ Wed, Mar 21st 2012 ] - Market Wire

Ronald L. Chez Files Amended Repligen 13D Urging .. ositive Director Action on Behalf of Shareholders

[ Wed, Mar 21st 2012 ] - Market Wire

Teva Pharmaceutical Industries Ltd. to Transfer Listing to NYSE

[ Wed, Mar 21st 2012 ] - Market Wire

Data on ELIQUIS (apixaban) for the Prevention of .. to Be Presented at American College of Cardiolog

[ Wed, Mar 21st 2012 ] - Market Wire

Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company

[ Wed, Mar 21st 2012 ] - Market Wire

RevNutrition.com to Carry MedPodium Nutra-Apps Brand

[ Wed, Mar 21st 2012 ] - Market Wire

Response Genetics, Inc. to Release Fourth Quarter .. Results and Host Conference Call on March 27, 20

[ Wed, Mar 21st 2012 ] - Market Wire

Abiomed Appoints Susan Vissers Lisa as Senior Dir .. r of Investor Relations and Corporate Development

[ Wed, Mar 21st 2012 ] - Market Wire

Paladin Labs Announces Canadian Approval for Oralair(TM)

[ Wed, Mar 21st 2012 ] - Market Wire

iBio Announces Successful Completion of H1N1 Influenza Vaccine Phase 1 Clinical Trial

[ Wed, Mar 21st 2012 ] - Market Wire

Acura Pharmaceuticals to Present at the Needham Healthcare Conference on April 3, 2012

[ Wed, Mar 21st 2012 ] - Market Wire

Implant Sciences Receives Patent for Narcotics and Explosives Particle Removal System

[ Wed, Mar 21st 2012 ] - Market Wire

Bioline Receives Clearance from TGA for the Comme .. the New Molecular Test illumigene Group B Strepto

[ Wed, Mar 21st 2012 ] - Market Wire

Community Health Systems, Inc. Announces Early Te .. r Offer Results for Its 8?% Senior Notes Due 2015

[ Wed, Mar 21st 2012 ] - Market Wire

Astex Pharmaceuticals Announces March 27th Analyst and Investor Day Agenda

[ Wed, Mar 21st 2012 ] - Market Wire

Genomic Health Announces Presentation of Three On .. dies at the 8th European Breast Cancer Conference

Tue, March 20, 2012

[ Tue, Mar 20th 2012 ] - Market Wire

Galapagos delivers candidate drug in its alliance .. Pharmaceutica, NV and receives milestone payment

[ Tue, Mar 20th 2012 ] - Market Wire

Faruqi amp;; Faruqi, LLP Announces Investigation of ZELTIQ Aesthetics, Inc.

[ Tue, Mar 20th 2012 ] - Market Wire

FDA Grants Lexicon Orphan Drug Designation for Te .. Etiprate for the Treatment of Carcinoid Syndrome

[ Tue, Mar 20th 2012 ] - Market Wire

Centene Schedules 2012 First Quarter Financial Re .. ce Call and Announces 2012 Annual Meeting Webcast

[ Tue, Mar 20th 2012 ] - Market Wire

Success of Cardio Cuts Drives New Product Growth for Bond

[ Tue, Mar 20th 2012 ] - Market Wire

CML HealthCare Inc. Declares March Dividend

[ Tue, Mar 20th 2012 ] - Market Wire

Dyax Kicks Off Fundraising Activities in Honor of .. al Event to Raise Awareness of Hereditary Angioed

[ Tue, Mar 20th 2012 ] - Market Wire

Roche files definitive proxy statement

[ Tue, Mar 20th 2012 ] - Market Wire

ActiveCare Acquires Approximately 1,300 Members T .. cquired and Wholly Owned Subsidiary 4G Biometrics

[ Tue, Mar 20th 2012 ] - Market Wire

Cardium Initiates Generx Phase 3 Clinical Registration Study

[ Tue, Mar 20th 2012 ] - Market Wire

Syneron Takes Voluntary Field Action Regarding the LiteTouch Dental Laser Product in Europe

[ Tue, Mar 20th 2012 ] - Market Wire

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

[ Tue, Mar 20th 2012 ] - Market Wire

WESTMED Medical Group Launches Accountable Care O .. in Collaboration with UnitedHealthcare and Optum

[ Tue, Mar 20th 2012 ] - Market Wire

Boston Scientific Announces New Clinical Data to .. 2012 on the Market-Leading PROMUS Elementa" Stent

[ Tue, Mar 20th 2012 ] - Market Wire

CareFusion Announces 510(k) Clearance and U.S. Launch of New Advanced Electrodiagnostic System

[ Tue, Mar 20th 2012 ] - Market Wire

Cytomedix to Host 2011 Financial Results Conference Call on Friday, March 30, 2012

[ Tue, Mar 20th 2012 ] - Market Wire

Hamilton Thorne Launches XYRCOS(TM) Laser System .. luding Stem Cell Research, Gene Targeting and Las

[ Tue, Mar 20th 2012 ] - Market Wire

Study Published in International Journal of Oncol .. RNAs to Determine Risk of Recurrence in Colorecta

AVI BioPharma to Present Company Overview at the 11th Annual Needham Healthcare Conference

_{//health-fitness.news-articles.net/content/2012/ .. e-11th-annual-needham-healthcare-conference.html}
^{Published in Health and Fitness on Tuesday, March 27th 2012 at 5:37 GMT by Market Wire}

March 27, 2012 08:30 ET

AVI BioPharma to Present Company Overview at the 11th Annual Needham Healthcare Conference

Webcast Accessible via AVI Website

BOTHELL, WA--(Marketwire - Mar 27, 2012) - AVI BioPharma, Inc. (NASDAQ: [ AVII ]), a developer of RNA-based therapeutics, announced today that the Company is scheduled to present at the 11th Annual Needham Healthcare Conference in New York, NY on Tuesday, April 3, at 2:40 p.m. Eastern Time. Chris Garabedian, AVI's president and CEO, will provide a company overview.

The presentation will be webcast live under the events section of AVI's website at [ www.avibio.com ] and will be archived there following the presentation for 90 days. Please connect to AVI's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About AVI BioPharma
AVI BioPharma is focused on the discovery and development of novel RNA-based therapeutics for rare and infectious diseases, as well as other select disease targets. Applying pioneering technologies developed and optimized by AVI, the Company is able to target a broad range of diseases and disorders through distinct RNA-based mechanisms of action. Unlike other RNA-based approaches, AVI's technologies can be used to directly target both messenger RNA (mRNA) and precursor messenger RNA (pre-mRNA) to either down-regulate (inhibit) or up-regulate (promote) the expression of targeted genes or proteins. By leveraging its highly differentiated RNA-based technology platform, AVI has built a pipeline of potentially transformative therapeutic agents, including eteplirsen, which is in clinical development for the treatment of Duchenne muscular dystrophy, and multiple drug candidates that are in clinical development for the treatment of infectious disease. For more information, please visit [ www.avibio.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire